Hematology Analyzers Global Market Report 2025

The hematology analyzers market size has grown strongly in recent years. It will grow from $3.78 billion in 2024 to $4.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the increasing prevalence of blood disorders, a growing aging population, rising health awareness, improvements in healthcare infrastructure, and enhanced government support for health initiatives.

The hematology analyzers market size is expected to see strong growth in the next few years. It will grow to $5.3 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to the increasing incidence of chronic diseases, the expansion of diagnostic laboratories, rising demand for personalized medicine, growing health consciousness, and an aging global population. Key trends expected during this period include the integration of artificial intelligence (AI) and machine learning, device miniaturization, adoption of cloud-based data management systems, advancements in automation and robotics, and the emergence of wearable hematology monitoring devices.

The increasing incidence of blood disorders is expected to drive the growth of the hematology analyzers market in the future. Blood disorders are conditions that affect various components of the blood, such as red blood cells, white blood cells, platelets, or plasma. This rise is largely linked to the growing prevalence of chronic diseases that impact blood health and require continuous monitoring. Hematology analyzers assist in diagnosing these disorders by delivering precise and rapid analysis of blood components, allowing for early detection and treatment. They support better clinical decision-making, which leads to improved patient care and outcomes. For example, in April 2024, the Perth Blood Institute, an Australia-based non-profit organization, reported that the number of individuals diagnosed with hemophilia - a genetic blood disorder characterized by impaired clotting and prolonged bleeding - reached 257,146 in 2022, up from 233,577 in 2021. Thus, the rising prevalence of blood disorders is fueling the growth of the hematology analyzers market.

Leading companies in the hematology analyzers market are concentrating on developing technologically advanced products, such as automated hematology systems, to enhance diagnostic accuracy, improve workflow efficiency, and provide faster test results with minimal manual effort. Automated hematology systems are sophisticated diagnostic machines used in clinical laboratories to conduct a range of hematological tests with little human intervention. For example, in January 2024, Horiba Medical, a Japan-based medical diagnostics company, introduced the HELO 2 high-throughput automated hematology platform, which is approved under the Conformité Européenne In Vitro Diagnostic Regulation (CE-IVDR) and is awaiting approval from the United States Food and Drug Administration (FDA). The HELO 2 delivers a flexible, scalable, and efficient modular solution tailored for mid- to large-scale laboratories. It incorporates advanced technologies from the Yumizen H2500 and H1500 analyzers, ensuring superior performance with 360-degree sample mixing, optimized turnaround time, space efficiency, and reagent storage. Additionally, it supports ISO-15189 accreditation, addressing all pre-analytical, analytical, and post-analytical requirements.

In June 2023, Mars Incorporated, a U.S.-based food company, acquired Heska Corporation for $1.3 billion. Through this acquisition, Mars intends to strengthen its position in the animal health diagnostics market, focusing especially on veterinary diagnostics, and to broaden its range of diagnostic solutions for veterinary professionals. Heska Corporation, also based in the U.S., specializes in veterinary diagnostics, including hematology analyzers.

Major players in the hematology analyzers market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, Horiba Medical Ltd., Nihon Kohden Corporation, Trivitron Healthcare Pvt. Ltd., Transasia Bio-Medicals Ltd., Erba Mannheim GmbH, Boule Diagnostics AB, Diatron MI PLC, Awareness Technology Inc., Analyticon Biotechnologies AG, Rayto Life and Analytical Sciences Co. Ltd., Diagon Ltd., Perlong Medical, Drew Scientific Inc., and PZ Cormay S.A.

North America was the largest region in the hematology analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hematology analyzers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hematology analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Hematology analyzers are automated laboratory devices designed to count and analyze blood cells, including red blood cells, white blood cells, and platelets. They are essential for diagnosing and monitoring medical conditions such as anemia, infections, clotting disorders, and blood cancers. The primary function of these analyzers is to deliver accurate, fast, and detailed blood test results to aid clinical decision-making.

There are two main types of hematology analyzers including fully automated and semi-automated. Fully automated hematology analyzers are sophisticated systems that conduct complete blood analyses with minimal manual input, handling tasks such as sample preparation, cell counting, and result interpretation automatically. These analyzers are composed of various components, including instruments, reagents, and consumables, and are available in two key modalities: standalone systems and point-of-care devices. They employ advanced technologies like flow cytometry, electrical impedance, and optical methods, serving end users such as hospitals, clinical laboratories, research institutions, and others.

The hematology analyzers market research report is one of a series of new reports that provides hematology analyzers market statistics, including the hematology analyzers industry global market size, regional shares, competitors with the hematology analyzers market share, detailed hematology analyzers market segments, market trends, and opportunities, and any further data you may need to thrive in the hematology analyzers industry. This hematology analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hematology analyzers market consists of sales of electrolyte analyzers, microplate readers, and diagnostic blood testing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.